Gurpreet Reen

My PhD research is based on understanding and recall of medication risk-benefit information by people with Multiple Sclerosis (MS), supervised by Prof. Dawn Langdon, and in collaboration with Dr. Eli Silber at King’s College Hospital and Queen Elizabeth Hospital. I propose to develop a generic protocol to be used for risk and benefit information in MS medications, with findings obtained from surveys and experiments with MS patients and MS health professionals in this research project. This protocol will be known as: Benefit and Risk Information for Medication in Multiple Sclerosis (BRIMMS).

Before beginning my PhD in February 2014, I was based at the University of Oxford, working on a longitudinal study with children in early school years who had previously completed a vocabulary checklist as babies, the Oxford Communicative Development Inventory (OCDI), to identify whether early vocabulary predicts later reading and language development. I have also previously worked as an Assistant Psychologist at the Central and North West London NHS Trust (CNWL).

2011 Bsc (Hons) Psychology, Royal Holloway, University of London